Home 
Categories Prostate Cancer Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality - Abstract
Categories Prostate Cancer Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality - AbstractPeriodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality - Abstract
Published on 21 August 2012
QUESTION:In men 55 to 69 years of age, does periodic prostate-specific antigen (PSA)-based screening reduce risk for prostate cancer mortality?
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags:
